Used as a key intermediate in the synthesis of quinazoline-based pharmaceuticals, particularly in the development of tyrosine kinase inhibitors for cancer treatment. Its structure allows for selective substitution at the 4-position, enabling the creation of targeted therapies with improved efficacy and reduced side effects. Also employed in research for designing novel antimicrobial and anti-inflammatory agents due to its electron-deficient aromatic core and hydrogen bonding capability.